Boston Scientific Scores Big Win In Patent Dispute

Law360, New York (May 30, 2006, 12:00 AM EDT) -- A federal appeals court gave Boston Scientific Corporation the green light to take a bite out of the multi-billion dollar U.S. market for drug-coated coronary stents last week when it affirmed two lower court rulings holding that Boston Scientific’s stents did not infringe on four patents held by Medtronic Inc.

A ruling against Boston Scientific would have left Johnson & Johnson as the sole distributor of drug-eluting stents in the U.S. But Friday's decision by the Court of Appeals for the Federal Circuit cleared the way...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.